These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36712997)

  • 1. Predilation Ballooning in High Thrombus Laden STEMIs: An Independent Predictor of Slow Flow/No-Reflow in Patients Undergoing Emergent Percutaneous Coronary Revascularization.
    Kumar R; Qayyum D; Ahmed I; Rai L; Mir A; Awan R; Naseer AB; Basit A; Sial JA; Saghir T; Qamar N; Karim M
    J Interv Cardiol; 2023; 2023():4012361. PubMed ID: 36712997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification Of Thrombus Burden As An Independent Predictor Of Intra-Procedural No-Reflow In Patients With St-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Revascularization.
    Kumar R; Khan KA; Shah JA; Ammar A; Kumar D; Khowaja S; Sial JA; Kazmi S; Murtaza M; Karim M
    J Ayub Med Coll Abbottabad; 2022; 34(2):288-294. PubMed ID: 35576288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Validation of a Novel Risk Stratification Model for Slow-Flow/No-Reflow During Primary Percutaneous Coronary Intervention (the RK-SF/NR Score).
    Kumar R; Ammar A; Saghir T; Sial JA; Khan KA; Shah JA; Shaikh AH; Rizvi SNH; Qamar N; Karim M
    Am J Cardiol; 2022 May; 171():32-39. PubMed ID: 35305786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of no-reflow phenomenon following percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Aggarwal P; Rekwal L; Sinha SK; Nath RK; Khanra D; Singh AP
    Ann Cardiol Angeiol (Paris); 2021 Jun; 70(3):136-142. PubMed ID: 33962782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel predictors and adverse long-term outcomes of No-reflow phenomenon in patients with acute ST elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Refaat H; Tantawy A; Gamal AS; Radwan H
    Indian Heart J; 2021; 73(1):35-43. PubMed ID: 33714407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of High-Risk Patients After ST-Segment-Elevation Myocardial Infarction: Comparison Between Angiographic and Magnetic Resonance Parameters.
    Durante A; Laricchia A; Benedetti G; Esposito A; Margonato A; Rimoldi O; De Cobelli F; Colombo A; Camici PG
    Circ Cardiovasc Imaging; 2017 Jun; 10(6):e005841. PubMed ID: 28592591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHA2DS2-VASc score predicts the slow flow/no-reflow phenomenon in ST-segment elevation myocardial infarction patients with multivessel disease undergoing primary percutaneous coronary intervention.
    Huang X; Zheng W; Zhao XD; Nie SP
    Medicine (Baltimore); 2021 May; 100(21):e26162. PubMed ID: 34032776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between kaolin-induced maximum amplitude and slow-flow/no-reflow in ST elevation myocardial infarction patients treated with primary percutaneous coronary intervention.
    Li Q; Xie E; Tu Y; Wu Y; Guo Z; Li P; Li Y; Yu X; Ye Z; Yu C; Gao Y; Jingang Z
    Int J Cardiol; 2022 Dec; 369():13-18. PubMed ID: 35970443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of initial and residual thrombus burden on the no-reflow phenomenon in patients with ST-segment elevation myocardial infarction.
    Ahn SG; Choi HH; Lee JH; Lee JW; Youn YJ; Yoo SY; Cho BR; Lee SH; Yoon J
    Coron Artery Dis; 2015 May; 26(3):245-53. PubMed ID: 25503419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A high-volume single center experience of no-reflow post-percutaneous coronary intervention].
    Durante A; Latib A; Pizzetti G; Colombo A; Camici PG
    G Ital Cardiol (Rome); 2014 Feb; 15(2):110-5. PubMed ID: 24625850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary artery ectasia, an independent predictor of no-reflow after primary PCI for ST-elevation myocardial infarction.
    Schram HCF; Hemradj VV; Hermanides RS; Kedhi E; Ottervanger JP;
    Int J Cardiol; 2018 Aug; 265():12-17. PubMed ID: 29731349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
    Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Predictors of the no-reflow phenomenon after primary percutaneous coronary intervention for acute myocardial infarction].
    Zhao Y; Chen Y; Tian F; Wang C; Hu S; Wang J; Yang J
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Feb; 32(2):261-4. PubMed ID: 22381773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-Lymphocyte ratio is a predictor for the development of no-reflow phenomenon in patients with ST-segment elevation myocardial infarction after thrombus aspiration.
    Şenöz O; Emren SV; Erseçgin A; Yapan Emren Z; Gül İ
    J Clin Lab Anal; 2021 Jun; 35(6):e23795. PubMed ID: 33945171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between serum rheumatoid factor level and no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Quisi A; Alıcı G
    J Clin Lab Anal; 2018 Nov; 32(9):e22598. PubMed ID: 29943408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shock Index on Admission Is Associated with Coronary Slow/No Reflow in Patients with Acute Myocardial Infarction Undergoing Emergent Percutaneous Coronary Intervention.
    Wang Q; Shen H; Mao H; Yu F; Wang H; Zheng J
    J Interv Cardiol; 2019; 2019():7873468. PubMed ID: 31772546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No-reflow phenomenon and comparison to the normal-flow population postprimary percutaneous coronary intervention for ST elevation myocardial infarction: case-control study (NORM PPCI).
    Rossington JA; Sol E; Masoura K; Aznaouridis K; Chelliah R; Cunnington M; Davison B; John J; Oliver R; Hoye A
    Open Heart; 2020 Jul; 7(2):. PubMed ID: 32719072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Predictive Value of Baseline Target Lesion SYNTAX Score for No-Reflow during Urgent Percutaneous Coronary Intervention in Acute Myocardial Infarction.
    Gao G; Xu H; Zhang D; Song C; Guan C; Xu B; Yin D; Dou K
    J Interv Cardiol; 2021; 2021():9987265. PubMed ID: 34404984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-graft abciximab and verapamil combined with direct stenting is a safe and effective strategy to prevent slow-flow and no-reflow phenomenon in saphenous vein graft lesions not associated with thrombus.
    Sharma S; Lardizabal JA; Singh S; Sandhu R; Bhambi BK
    Recent Pat Cardiovasc Drug Discov; 2012 Aug; 7(2):152-9. PubMed ID: 22559269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of no-reflow in culprit lesion versus culprit vessel PCI in acute STEMI.
    Arslan U; Yaman M; Kocaoğlu İ; Turan OE; Yücel H; Aksakal A; Günaydin İA; Hakan Ateş A
    Coron Artery Dis; 2015 Sep; 26(6):510-5. PubMed ID: 26086864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.